COVID-19 vaccines: challenges and solutions

被引:5
作者
Mohseni Afshar, Zeinab [1 ]
Babazadeh, Arefeh [2 ]
Janbakhsh, Alireza [1 ]
Afsharian, Mandana [1 ]
Ebrahimpour, Soheil [2 ]
机构
[1] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran
[2] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Hlth Res Inst, Babol, Iran
来源
MINERVA RESPIRATORY MEDICINE | 2021年 / 60卷 / 04期
关键词
SARS-CoV-2; COVID-19; Vaccines; DISEASE; 2019; COVID-19; NEED;
D O I
10.23736/S2784-8477.21.01921-0
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global emergency by the World Health Organization (WHO). Several ways have been used to control and manage the COVID-19 pandemic. Among them, development of vaccines could be an important breakthrough against novel virus. It is important to note that the candidate vaccine is expected to work against infection and transmission. To date, many COVID-19 vaccine clinical trials have been registered worldwide. However, some vaccine candidates could meet adequate standards for effectiveness and safety. In the current review, we discussed the effectiveness, safety, target population, and hesitancy of COVID-19 vaccines.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 37 条
[31]  
Tanne J.H., 2020, COVID 19 FDA PANEL V
[32]  
Thompson SA, 2020, LONG WILL VACCINE RE
[33]   As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention [J].
Travis, Craig R. .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[34]   Next-generation vaccine platforms for COVID-19 [J].
van Riel, Debby ;
de Wit, Emmie .
NATURE MATERIALS, 2020, 19 (08) :810-812
[35]   Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates [J].
Walsh, Edward E. ;
Frenck, Robert W., Jr. ;
Falsey, Ann R. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Neuzil, Kathleen ;
Mulligan, Mark J. ;
Bailey, Ruth ;
Swanson, Kena A. ;
Li, Ping ;
Koury, Kenneth ;
Kalina, Warren ;
Cooper, David ;
Fontes-Garfias, Camila ;
Shi, Pei-Yong ;
Tuereci, Oezlem ;
Tompkins, Kristin R. ;
Lyke, Kirsten E. ;
Raabe, Vanessa ;
Dormitzer, Philip R. ;
Jansen, Kathrin U. ;
Sahin, Ugur ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2439-2450
[36]   Current Status of COVID-19 (Pre)Clinical Vaccine Development [J].
Ye, Tingting ;
Zhong, Zifu ;
Garcia-Sastre, Adolfo ;
Schotsaert, Michael ;
De Geest, Bruno G. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (43) :18885-18897
[37]   A Thermostable mRNA Vaccine against COVID-19 [J].
Zhang, Na-Na ;
Li, Xiao-Feng ;
Deng, Yong-Qiang ;
Zhao, Hui ;
Huang, Yi-Jiao ;
Yang, Guan ;
Huang, Wei-Jin ;
Gao, Peng ;
Zhou, Chao ;
Zhang, Rong-Rong ;
Guo, Yan ;
Sun, Shi-Hui ;
Fan, Hang ;
Zu, Shu-Long ;
Chen, Qi ;
He, Qi ;
Cao, Tian-Shu ;
Huang, Xing-Yao ;
Qiu, Hong-Ying ;
Nie, Jian-Hui ;
Jiang, Yuhang ;
Yan, Hua-Yuan ;
Ye, Qing ;
Zhong, Xia ;
Xue, Xia-Lin ;
Zha, Zhen-Yu ;
Zhou, Dongsheng ;
Yang, Xiao ;
Wang, You-Chun ;
Ying, Bo ;
Qin, Cheng-Feng .
CELL, 2020, 182 (05) :1271-+